SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 48.86+3.7%Feb 10 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (2065)11/20/2000 7:06:39 PM
From: tom pope  Read Replies (1) of 52153
 
>>By all means report R&D expenditure as a separate item, but remember that it's still expenditure<<

And building a lab or equipping that lab is "still expenditure". Do you think the cost of building the lab should be expensed rather than capitalized?

The amounts expended on R&D create an asset called intellectual property. If the IP turns out to be valueless, it should be written off, just as the capitalized cost of building the lab should be written off when it no longer is of economic benefit to the firm.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News